NCT05963828Completed
Comprehensive Management of High-risk PopuLatIon for Stroke Based on Social Network
COmprehensive Management of High-risk PopuLatIon for Stroke bAsed oN soCial nEtwork: A Multicenter Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 12 May 2026
Brief summary (registry, in English)
The purpose of this study is to evaluate the effectiveness of social network in improving drug compliance and risk factors control rate of stroke high-risk population after discharge.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 720 (actual)
- First submitted
- 14 Apr 2023
- Start date
- 19 Jul 2023
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- Changhai Hospital
- Diseases
- Stroke
- NCT number
- NCT05963828
What you commit to
- Study type: Interventional
- Participants enrolled: 720
- From 19 Jul 2023 to the primary completion date, 30 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent participation in other clinical trials.
Other illness
- Comorbidities potentially confounding outcome assessments, including Advanced malignancies (life expectancy \<12 months); Documented dementia; Severe psychiatric disorders (e.g., schizophrenia, major depressive disorder).
- Any condition deemed by investigators to preclude safe trial participation.
Other
- Inability to operate smartphones (patient or caregiver).
- Residence in areas with unreliable internet access.
Who the study is looking for
- Age ≥18 years.
- Hospitalized patients at high risk of stroke are those who have at least three of the following risk factors: hypertension, dyslipidemia, diabetes, atrial fibrillation/valvular disease, smoking history, overweight/obesity, physical inactivity, or family stroke history; or those with a history of prior transient ischemic attack (TIA) or stroke.12
- modified Rankin Scale (mRS) score ≤2.
- Smartphone/WeChat access (patient or caregiver).
- Informed consent obtained.
- Active long-term therapy: ≥1 medication (antihypertensive, hypoglycemic, lipid-lowering, anticoagulant, antiplatelet).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Changhai Hospital Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.